Parkinson's Disease: is It a Toxic Syndrome?

Overview

Journal Neurol Res Int

Publisher Wiley

Specialty Neurology

Date 2010 Dec 15

PMID 21152209

Citations 1

Authors

Seham A Gad Elhak

Abdel Aziz A Ghanem

Hassan Abdelghaffar

Sahar El Dakroury

Mohamed M Salama

Affiliations

Soon will be listed here.

Abstract

Parkinson's disease (PD) is one of the neurodegenerative diseases which we can by certainty identify its pathology, however, this confidence disappeares when talking about the cause. A long history of trials, suggestions, and theories tried linking PD to a specific causation. In this paper, a new suggestion is trying to find its way, could it be toxicology? Can we-in the future-look to PD as an occupational disease, in fact, many clues point to the possible toxic responsibility-either total or partial-in causing this disease. Searching for possible toxic causes for PD would help in designing perfect toxic models in animals.

Citing Articles

Quercetin Attenuates Copper-Induced Apoptotic Cell Death and Endoplasmic Reticulum Stress in SH-SY5Y Cells by Autophagic Modulation.

Chakraborty J, Pakrashi S, Sarbajna A, Dutta M, Bandyopadhyay J Biol Trace Elem Res. 2022; 200(12):5022-5041.

PMID: 35149956 DOI: 10.1007/s12011-022-03093-x.

References

Zhang Y, Gao J, Chung K, Huang H, Dawson V, Dawson T . Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1. Proc Natl Acad Sci U S A. 2000; 97(24):13354-9. PMC: 27228. DOI: 10.1073/pnas.240347797. View

Betarbet R, Canet-Aviles R, Sherer T, Mastroberardino P, McLendon C, Kim J . Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system. Neurobiol Dis. 2006; 22(2):404-20. DOI: 10.1016/j.nbd.2005.12.003. View

Prasad K, Tarasewicz E, Mathew J, Ohman Strickland P, Buckley B, Richardson J . Toxicokinetics and toxicodynamics of paraquat accumulation in mouse brain. Exp Neurol. 2008; 215(2):358-67. PMC: 4016858. DOI: 10.1016/j.expneurol.2008.11.003. View

Hancock D, Martin E, Mayhew G, Stajich J, Jewett R, Stacy M . Pesticide exposure and risk of Parkinson's disease: a family-based case-control study. BMC Neurol. 2008; 8:6. PMC: 2323015. DOI: 10.1186/1471-2377-8-6. View

Kannan K, Holcombe R, Jain S, Chervenak R, Wolf R, Glass J . Evidence for the induction of apoptosis by endosulfan in a human T-cell leukemic line. Mol Cell Biochem. 2000; 205(1-2):53-66. DOI: 10.1023/a:1007080910396. View

Ramachandiran S, Hansen J, Jones D, Richardson J, Miller G . Divergent mechanisms of paraquat, MPP+, and rotenone toxicity: oxidation of thioredoxin and caspase-3 activation. Toxicol Sci. 2006; 95(1):163-71. DOI: 10.1093/toxsci/kfl125. View

Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, DAlessio A . Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol Lett. 2003; 139(2-3):125-33. DOI: 10.1016/s0378-4274(02)00427-7. View

Elbaz A, Tranchant C . Epidemiologic studies of environmental exposures in Parkinson's disease. J Neurol Sci. 2007; 262(1-2):37-44. DOI: 10.1016/j.jns.2007.06.024. View

Monti B, Gatta V, Piretti F, Raffaelli S, Virgili M, Contestabile A . Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein. Neurotox Res. 2009; 17(2):130-41. DOI: 10.1007/s12640-009-9090-5. View

10.

Uversky V . Neurotoxicant-induced animal models of Parkinson's disease: understanding the role of rotenone, maneb and paraquat in neurodegeneration. Cell Tissue Res. 2004; 318(1):225-41. DOI: 10.1007/s00441-004-0937-z. View

11.

Di Monte D . The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?. Lancet Neurol. 2003; 2(9):531-8. DOI: 10.1016/s1474-4422(03)00501-5. View

12.

Galvan A, Wichmann T . Pathophysiology of parkinsonism. Clin Neurophysiol. 2008; 119(7):1459-74. PMC: 2467461. DOI: 10.1016/j.clinph.2008.03.017. View

13.

Tsai C, Lo S, See L, Chen H, Chen R, Weng Y . Environmental risk factors of young onset Parkinson's disease: a case-control study. Clin Neurol Neurosurg. 2002; 104(4):328-33. DOI: 10.1016/s0303-8467(02)00027-6. View

14.

Shimohama S, Sawada H, Kitamura Y, Taniguchi T . Disease model: Parkinson's disease. Trends Mol Med. 2003; 9(8):360-5. DOI: 10.1016/s1471-4914(03)00117-5. View

15.

Corti O, Hampe C, Darios F, Ibanez P, Ruberg M, Brice A . Parkinson's disease: from causes to mechanisms. C R Biol. 2005; 328(2):131-42. DOI: 10.1016/j.crvi.2004.10.009. View

16.

Iacovelli L, Fulceri F, de Blasi A, Nicoletti F, Ruggieri S, Fornai F . The neurotoxicity of amphetamines: bridging drugs of abuse and neurodegenerative disorders. Exp Neurol. 2006; 201(1):24-31. DOI: 10.1016/j.expneurol.2006.02.130. View

17.

Manning-Bog A, Langston J . Model fusion, the next phase in developing animal models for Parkinson's disease. Neurotox Res. 2007; 11(3-4):219-40. DOI: 10.1007/BF03033569. View

18.

Kanthasamy A, Kitazawa M, Kanthasamy A, Anantharam V . Dieldrin-induced neurotoxicity: relevance to Parkinson's disease pathogenesis. Neurotoxicology. 2005; 26(4):701-19. DOI: 10.1016/j.neuro.2004.07.010. View

19.

Tabarean I, Narahashi T . Kinetics of modulation of tetrodotoxin-sensitive and tetrodotoxin-resistant sodium channels by tetramethrin and deltamethrin. J Pharmacol Exp Ther. 2001; 299(3):988-97. View

20.

Schober A . Classic toxin-induced animal models of Parkinson's disease: 6-OHDA and MPTP. Cell Tissue Res. 2004; 318(1):215-24. DOI: 10.1007/s00441-004-0938-y. View